Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Change in Cash (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Change in Cash readings, the most recent being -$42.0 for Q1 2026.

  • On a quarterly basis, Change in Cash rose 90.75% to -$42.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$458.0, a 86.18% decrease, with the full-year FY2025 number at $12197.0, up 249.51% from a year prior.
  • Change in Cash reached -$42.0 in Q1 2026 per CBIH's latest filing, up from -$91.0 in the prior quarter.
  • The five-year high for Change in Cash was $12404.0 in Q2 2025, with the low at -$16742.0 in Q2 2023.
  • A 4-year average of -$1846.1 and a median of -$42.0 in 2026 define the central range for Change in Cash.
  • Peak annual rise in Change in Cash hit 31905.13% in 2025, while the deepest fall reached 6048.13% in 2025.
  • Year by year, Change in Cash stood at -$4409.0 in 2023, then surged by 100.75% to $33.0 in 2024, then plummeted by 375.76% to -$91.0 in 2025, then skyrocketed by 53.85% to -$42.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Change in Cash are -$42.0 (Q1 2026), -$91.0 (Q4 2025), and -$12729.0 (Q3 2025).